...
bngo-img

Bionano Genomics Inc, Common Stock

BNGO

NAQ

$0.7872

-$0.03

(-3.68%)

1D
Industry: Life Sciences Tools & Services Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$43.06M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
NM
Volume info-icon
This is the total number of shares traded during the most recent trading day.
2.37M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
1.73M
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.37
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.79 L
$8.2 H
$0.7872

About Bionano Genomics Inc, Common Stock

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. The company also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California. more

Industry: Life Sciences Tools & ServicesSector: Health Care

Returns

Time FrameBNGOSectorS&P500;
1-Week Return-23.57%-1.82%-3.38%
1-Month Return-22.82%-4.41%-2.74%
3-Month Return-35.48%-0.32%5.38%
6-Month Return-57.45%7.48%17.24%
1-Year Return-89.51%5.37%22.71%
3-Year Return-98.51%19.39%26.18%
5-Year Return-98.11%75.65%87.58%
10-Year Return-98.87%182.56%222.4%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue10.13M8.50M17.98M27.80M36.12M[{"date":"2019-12-31","value":28.05,"profit":true},{"date":"2020-12-31","value":23.54,"profit":true},{"date":"2021-12-31","value":49.79,"profit":true},{"date":"2022-12-31","value":76.98,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue6.77M5.73M14.11M21.86M26.55M[{"date":"2019-12-31","value":25.49,"profit":true},{"date":"2020-12-31","value":21.58,"profit":true},{"date":"2021-12-31","value":53.13,"profit":true},{"date":"2022-12-31","value":82.32,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit3.36M2.77M3.87M5.95M9.57M[{"date":"2019-12-31","value":35.14,"profit":true},{"date":"2020-12-31","value":28.99,"profit":true},{"date":"2021-12-31","value":40.5,"profit":true},{"date":"2022-12-31","value":62.15,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin33.18%32.61%21.54%21.38%26.49%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":98.27,"profit":true},{"date":"2021-12-31","value":64.93,"profit":true},{"date":"2022-12-31","value":64.44,"profit":true},{"date":"2023-12-31","value":79.82,"profit":true}]
Operating Expenses29.24M41.32M80.97M137.64M148.99M[{"date":"2019-12-31","value":19.62,"profit":true},{"date":"2020-12-31","value":27.74,"profit":true},{"date":"2021-12-31","value":54.35,"profit":true},{"date":"2022-12-31","value":92.38,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(25.87M)(38.55M)(77.10M)(131.70M)(139.43M)[{"date":"2019-12-31","value":-2587490600,"profit":false},{"date":"2020-12-31","value":-3855132200,"profit":false},{"date":"2021-12-31","value":-7710100000,"profit":false},{"date":"2022-12-31","value":-13169800000,"profit":false},{"date":"2023-12-31","value":-13942700000,"profit":false}]
Total Non-Operating Income/Expense(6.23M)(5.07M)(1.74M)2.19M(94.81M)[{"date":"2019-12-31","value":-283.66,"profit":false},{"date":"2020-12-31","value":-231.16,"profit":false},{"date":"2021-12-31","value":-79.36,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-4319.45,"profit":false}]
Pre-Tax Income(29.82M)(41.11M)(78.15M)(130.71M)(232.43M)[{"date":"2019-12-31","value":-2981507000,"profit":false},{"date":"2020-12-31","value":-4110635100,"profit":false},{"date":"2021-12-31","value":-7815200000,"profit":false},{"date":"2022-12-31","value":-13071200000,"profit":false},{"date":"2023-12-31","value":-23243100000,"profit":false}]
Income Taxes21.05K29.19K(5.72M)1.88M62.00K[{"date":"2019-12-31","value":1.12,"profit":true},{"date":"2020-12-31","value":1.55,"profit":true},{"date":"2021-12-31","value":-303.45,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":3.29,"profit":true}]
Income After Taxes(29.84M)(41.14M)(72.44M)(132.60M)(232.49M)[{"date":"2019-12-31","value":-2983611800,"profit":false},{"date":"2020-12-31","value":-4113554400,"profit":false},{"date":"2021-12-31","value":-7243500000,"profit":false},{"date":"2022-12-31","value":-13259600000,"profit":false},{"date":"2023-12-31","value":-23249300000,"profit":false}]
Income From Continuous Operations(29.82M)(41.11M)(72.44M)(132.60M)(232.49M)[{"date":"2019-12-31","value":-2981507000,"profit":false},{"date":"2020-12-31","value":-4110635100,"profit":false},{"date":"2021-12-31","value":-7243500000,"profit":false},{"date":"2022-12-31","value":-13259600000,"profit":false},{"date":"2023-12-31","value":-23249300000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(29.84M)(41.14M)(72.44M)(132.60M)(232.49M)[{"date":"2019-12-31","value":-2983611800,"profit":false},{"date":"2020-12-31","value":-4113554400,"profit":false},{"date":"2021-12-31","value":-7243500000,"profit":false},{"date":"2022-12-31","value":-13259600000,"profit":false},{"date":"2023-12-31","value":-23249300000,"profit":false}]
EPS (Diluted)(2.37)(0.52)(0.25)(0.46)(3.32)[{"date":"2019-12-31","value":-237,"profit":false},{"date":"2020-12-31","value":-52,"profit":false},{"date":"2021-12-31","value":-25,"profit":false},{"date":"2022-12-31","value":-46,"profit":false},{"date":"2023-12-31","value":-331.93,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

BNGO
Cash Ratio 1.02
Current Ratio 1.40
Quick Ratio 1.17

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

BNGO
ROA (LTM) -33.39%
ROE (LTM) -134.56%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

BNGO
Debt Ratio Lower is generally better. Negative is bad. 0.55
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.45
Debt/Equity The higher the number, the more leverage the business employs, the riskier the investment typically is. 2.23

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

BNGO
Trailing PE NM
Forward PE NM
P/S (TTM) 1.66
P/B 0.62
Price/FCF NM
EV/R 1.03
EV/Ebitda NM
PEG 0.00

News

BioNano Genomics Launches Offering to Bolster Finances

The latest announcement is out from BioNano Genomics Inc (BNGO). Bionano Genomics, Inc. has initiated a registered direct offering, securing an agr…

5 Apr, 2024 a 1:42 pm TipRanks

A New Cause for Concern: Bionano Genomics Adds a New Share Price & Shareholder Rights Risk

Bionano Genomics (BNGO) has disclosed a new risk, in the Share Price & Shareholder Rights category. Bionano Genomics encountered a significant busi…

7 Mar, 2024 a 6:01 am TipRanks

Bionano Genomics (BNGO) Q4 2023 Earnings Call Transcript

BNGO earnings call for the period ending December 31, 2023.

6 Mar, 2024 a 5:30 am The Motley Fool

Q4 2023 Bionano Genomics Inc Earnings Call Transcript

Q4 2023 Bionano Genomics Inc Earnings Call Transcript

6 Mar, 2024 a 5:01 am GuruFocus

BNGO Stock Earnings: Bionano Genomics Misses EPS, Beats Revenue for Q4 2023

Bionano Genomics (NASDAQ: BNGO ) just reported results for the fourth quarter of 2023. Bionano Genomics reported earnings per share of -96 cents. This was below the analyst estimate for EPS of -87 cents. The company reported revenue of $10.72 million. This was 1.33% better than the analyst estimate for revenue of $10.58 million. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com. More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move Before the Announcement Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.

6 Mar, 2024 a 4:51 am InvestorPlace

FAQs

What is Bionano Genomics Inc share price today?

Bionano Genomics Inc (BNGO) share price today is $0.7872

Can Indians buy Bionano Genomics Inc shares?

Yes, Indians can buy shares of Bionano Genomics Inc (BNGO) on Vested. To buy Bionano Genomics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BNGO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Bionano Genomics Inc be purchased?

Yes, you can purchase fractional shares of Bionano Genomics Inc (BNGO) via the Vested app. You can start investing in Bionano Genomics Inc (BNGO) with a minimum investment of $1.

How to invest in Bionano Genomics Inc shares from India?

You can invest in shares of Bionano Genomics Inc (BNGO) via Vested in three simple steps:

  • Click on Sign Up or Invest in BNGO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Bionano Genomics Inc shares
What is Bionano Genomics Inc 52-week high and low stock price?

The 52-week high price of Bionano Genomics Inc (BNGO) is $8.2. The 52-week low price of Bionano Genomics Inc (BNGO) is $0.79.

What is Bionano Genomics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Bionano Genomics Inc (BNGO) is NM

What is Bionano Genomics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Bionano Genomics Inc (BNGO) is 0.62

What is Bionano Genomics Inc dividend yield?

The dividend yield of Bionano Genomics Inc (BNGO) is 0.00%

What is the Market Cap of Bionano Genomics Inc?

The market capitalization of Bionano Genomics Inc (BNGO) is $43.06M

What is Bionano Genomics Inc’s stock symbol?

The stock symbol (or ticker) of Bionano Genomics Inc is BNGO

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top